Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
|
|
|
1,001-5,000 employees
View all Curaleaf employees
|
|
Alternative Medicine
|
|
420 Lexington Avenue, 2035, New York, New York 10170, US
|
|
None
|
Matthew Darin is the CEO of Curaleaf. To contact Matthew Darin email at [email protected] or [email protected]. Or you may call (312) 952-9862
The decision makers in Curaleaf are Adam Bartunek, Dustin Polo, Jim Smith, etc. Click to Find Curaleaf decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.